Tag: New England Journal of Medicine

Do Critics of Biological Psychiatry Have an Alternative to a Life of “Whack-A-Mole”?

Tina Marie (Ms. Cat)
Economic Manuscripts: Preface to A Contribution to the Critique of Political Economy

stablishment psychiatry has recently switched the biological cause of mental illness from a “chemical imbalance” to a “brain circuitry defect.” There is no more important institution in establishment psychiatry than the National Institute of Mental Health (NIMH), and in 2022, psychiatrist Thomas Insel, NIMH director from 2002-2015, stated in his book Healing, “The idea of mental illness as a ‘chemical imbalance’ has now given way to mental illnesses as ‘connectional’ or brain circuit disorders.”

Do Critics of Biological Psychiatry Have an Alternative to a Life of “Whack-A-Mole”?

Pfizer’s anti-COVID pill Paxlovid shows no benefit for younger adults

Tina Marie (Ms. Cat)

Pfizer’s anti-COVID pill Paxlovid shows no benefit for younger adults

The report’s authors found that Pfizer’s antiviral medication Paxlovid offered little to no benefit for younger adults. However, it did reduce the risk of hospitalization for high-risk seniors. Notably, supplementary material from the original study of Paxlovid in high-risk non-hospitalized adults with COVID-19 during the Delta wave had demonstrated benefits in those younger than 65, albeit the difference compared to the placebo was much less than in those 65 and older.

…

Among those over 65, there was a 73 percent decrease in the hospitalization rate and a 79 percent reduction in the risk of death. However, patients between the ages of 40 and 65 saw no benefit in taking the antiviral medication in either category, regardless of previous immunity status.

…

Another critical study from Hong Kong published in Lancet Infectious Diseases on the same day as the Israeli study but which went unmentioned in the press offered further evidence of Paxlovid’s limited therapeutic role. The authors reviewed their clinical experience with Paxlovid and Lagevrio, Merck’s antiviral pill, Molnupiravir, in hospitalized patients. They compared them to hospitalized patients who did not receive those medications during the horrific wave of infections that slammed into the semi-autonomous region in February and March.

…

The mortality risk reduction for Lagevrio was 52 percent, and for Paxlovid it was 66 percent. Those receiving antivirals had a lower risk of their disease progressing, but the drugs did not significantly impact their need for mechanical ventilation or ICU admission. The patients in the study averaged in age from mid-70s to early 80s.

…

Given the results of these studies, it bears mentioning that the Centers for Disease Control and Prevention (CDC) has recently estimated that approximately 95 percent of Americans aged 16 and older have some level of immunity against COVID-19.

Take the jab or lose your job: Medical journal calls for a MANDATORY Covid vaccine

Tina Marie (Ms. Cat)

‘Noncompliance should incur a penalty’ RT | October 1, 2020

The authors of the NEJM paper hail from Yale, Stanford University, and Indiana University, all institutions that have received funding from the Bill and Melinda Gates Foundation. The foundation has poured billions of dollars into developing multiple Covid-19 vaccines, setting up seven facilities to manufacture the leading candidates. While the US, UK, and several other countries have already paid for hundreds of millions of doses of multiple jabs, no western pharmaceutical company has yet declared victory in the vaccine race – on the contrary, the clinical trials of frontrunners like AstraZeneca and Moderna have yielded a bumper crop of troubling side effects.

Take the jab or lose your job: Medical journal calls for a MANDATORY Covid vaccine